FDA inspection
Eurofins BioPharma Product Testing Czech Republic s.r.o.: FDA inspection ending Jul 16, 2020
FDA inspection 1134811 · Voluntary Action Indicated (VAI) · Brno-Jih
Key facts
| Inspection ID | 1134811 |
|---|---|
| Firm | Eurofins BioPharma Product Testing Czech Republic s.r.o. |
| FEI number | 3008920466 |
| Address | Videnska 204/125 |
| City | Brno-Jih |
| Country | Czech Republic |
| Fiscal year | 2020 |
| Inspection end date | Jul 16, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data